Vision Testing Systems in Virginia

RetiVue LLC manufactures innovative widefield retinal imaging systems designed for early eye disease detection across all patient populations from infants to adults. The company's EntireEye product line delivers ultrawidefield retinal imaging (160° field of view on adults, 205° on infants) with 20MP true-color image quality at an affordable price point. Unlike traditional 45° fundus cameras, RetiVue's non-mydriatic technology captures up to ten times more retinal area per image, enabling comprehensive retinal screening without pupil dilation. Featuring point-and-shoot automatic image capture, the systems require minimal operator expertise while maintaining clinical-grade image quality. RetiVue's mission focuses on preventing blindness in underserved and medically at-risk populations through accessible, high-definition retinal documentation technology.

Sight Intelligence Engineering Corporation manufactures the SIE Better™, a VR-based visual field analyzer designed for glaucoma screening and monitoring. The device uses a patented AI adaptive algorithm to perform perimetry testing with reduced exam duration while maintaining sensitivity. Key features include gaze-based response detection (eliminating handheld clickers), active eye tracking with real-time fixation monitoring, wireless charging capability, and longitudinal progression analysis. The system is engineered for accessibility, enabling testing in patients with disabilities or dementia without protocol modification. The analyzer integrates with standard ophthalmic instrument stands and does not require dedicated darkroom space. Clinical design priorities include test accuracy, technician efficiency, and patient experience; surveyed patients report the experience as game-like rather than clinical. The company targets ophthalmology practices, glaucoma clinics, and healthcare systems requiring robust visual field testing capabilities. No specific FDA regulatory status or ISO certifications are stated on the website.

Marco Lombart is the nation's largest distributor of new and pre-owned ophthalmic equipment for optometry and ophthalmology practices, hospitals, universities, and US government agencies. The company distributes high-quality instruments and diagnostic systems from leading manufacturers including Canon, Haag-Streit, Heine, Hillrom, Keeler, Lightmed, Marco, Ocular Instruments, Reichert, Reliance, Sios, Sonomed Escalon, Volk, and Zeiss. Product portfolio includes slit lamps (Marco M5 Ultra, Haag-Streit Elara 900), automated refraction systems (Marco TRS-6100), fundus cameras (Marco Reticam 3100 Plus ultra-widefield), tonometry systems (Marco Tonoref II ARK, Reichert Tono-Pen AVIA), visual field analyzers (Optopol PTS 2000), examination chairs and stands (Lombart CS-6), and imaging systems (Marco iON). The company operates multiple regional offices across the United States and offers new and pre-owned equipment, equipment repair and maintenance services, protection plans, financing options, and customer support. Marco Lombart serves optometrists, ophthalmologists, academic institutions, and government entities with competitive pricing, rapid delivery, and comprehensive service capabilities.

NotAlVision Inc. is a digital health company specializing in remote patient monitoring services for retinal diseases, particularly age-related macular degeneration (AMD). The company develops home-based diagnostic devices operated by patients and AI-enabled data analysis platforms to extend eye disease management from traditional clinic settings into patients' homes. NotAlVision's platform addresses the unmet diagnostic need in ophthalmology by enabling real-time, automated analysis of patient testing data through proprietary AI algorithms. The company's approach aims to improve treatment outcomes by facilitating treatment decisions that align with each patient's disease activity timing rather than pre-scheduled clinic appointments. Key clinical focus areas include early detection of dry AMD progression to wet AMD, improving real-world wet AMD treatment outcomes, and optimizing treatment timing to reduce under-treatment. The platform connects patients and physicians 24/7 through a monitoring center and includes a suite of patient-operated home-based diagnostic devices. NotAlVision targets ophthalmology practices and retinal specialists seeking to improve patient engagement, diagnostic accuracy, and clinical outcomes in AMD management. The company combines precision medicine principles with telehealth capabilities to address the acute onset and unpredictable nature of retinal disease progression.